Precision Biosciences (DTIL) Return on Sales (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Return on Sales data on file, last reported at 0.01% in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.01%, up 728.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed N/A from the prior year.
• Return on Sales retreated to 0.01% in Q1 2026 per DTIL's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Sales peaked at 0.01% in Q2 2024 and troughed at 15.39% in Q3 2025.
• A 5-year average of 2.08% and a median of 0.01% in 2022 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2025 and 2026: Return on Sales sank 1504 bps in 2025, then soared 728 bps in 2026.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2022, then surged by 53 bps to 0.0% in 2023, then sank by 9074 bps to 0.37% in 2024, then surged by 101 bps to 0.0% in 2025, then plunged by 305 bps to 0.01% in 2026.
• Business Quant data shows DTIL's Return on Sales at 0.01% in Q1 2026, 0.0% in Q4 2025, and 15.39% in Q3 2025.